EIDO and C2-Ai announce strategic technology partnership
Posted:
EIDO and C2-Ai are delighted to announce a strategic technology partnership, bringing digital informed consent and big data into partnership for the benefit of clinicians and patients.
EIDO Healthcare has been providing its informed consent tools to hospitals for over 20 years, to support patients in making informed, joint decisions about their treatment.
In use by over 65% of acute NHS hospitals and 85% of acute private hospitals, across five continents and in use in over 1000 hospitals, EIDO’s solutions enhance patient experience, improve clinical workflow and protect organisational and clinical reputations.
Roche will roll out its Accu-Chek Smartguide in the Netherlands, Switzerland and Germany. The company hopes to stand out from competitors with features to predict hypoglycemia.
Read the full article here.
@cardmedic CEO Rachael has welcomed the report's admission that #patientcare is held back by outdated IT. "Using #technology to break down communication barriers, especially in some of the most urgent or unplanned situations, is crucial"
Read full article here.